Potentially inappropriate prescribing in Ethiopian geriatric patients hospitalized with cardiovascular disorders

Tadesse Melaku Abegaz1, Eshetie Melese Birru2, Gashaw Binega Mekonnen1

  • 1Department of clinical pharmacy, school of pharmacy, college of medicine and health sciences, university of Gondar, Gondar, Ethiopia.

Plos One
|May 4, 2018
PubMed

Insights

Potentially inappropriate prescriptions (PIPs) affected over two-thirds of elderly cardiovascular patients in Ethiopia. Longer hospital stays, comorbidities, and multiple discharge medications increased PIP risk, highlighting the need for medication review.

Area of Science:

  • Geriatric Medicine
  • Cardiology
  • Clinical Pharmacy

Background:

  • Limited data exists on potentially inappropriate prescriptions (PIPs) in elderly cardiovascular patients in Ethiopia.
  • Cardiovascular disorders are prevalent in the elderly population, increasing medication complexity and risk.

Purpose of the Study:

  • To determine the prevalence of PIPs in elderly Ethiopian cardiovascular patients.
  • To identify factors associated with PIPs using the Screening Tool of Older People's Prescriptions and Screening Tool to Alert to Right Treatment (STOPP/START) criteria.

Main Methods:

  • A hospital-based cross-sectional study was conducted in Ethiopia.
  • Medications of 239 elderly patients (≥65 years) with cardiovascular disorders were evaluated using STOPP/START criteria.
  • Multivariable logistic regression and ANOVA were used to analyze associated factors and differences in PIPs.

Main Results:

  • A high prevalence of PIPs (61.5%) was observed in 147 out of 239 patients.
  • Angiotensin Converting Enzyme Inhibitors (ACEIs) were the most frequent inappropriately prescribed medications (14.5%).
  • Factors increasing PIP likelihood included longer hospital stay (AOR: 1.086), more discharge medications (AOR: 1.924), and comorbidities (AOR: 3.127).

Conclusions:

  • Nearly two-thirds of elderly cardiovascular patients experienced PIPs, with ACEIs being commonly involved.
  • Longer hospital stays, comorbidities, and polypharmacy at discharge are significant risk factors for PIPs.
  • Implementing STOPP/START criteria during hospitalization is crucial for reducing PIPs in this vulnerable population.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
241
Hospitals-II00:59

Hospitals-II

Hospitals provide inpatient and outpatient services. Inpatient services provide care to patients that stay in the hospital for an extended period, ranging from days to months. Examples of inpatient services include intensive care units, hospital wards, or surgeries. Outpatient services provide care to patients who come to a hospital for a diagnostic or treatment but do not stay overnight —for example, diagnostic tests, surgical procedures, or health education.
Nurses that work in...
1.2K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
264
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
223
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
259